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ABSTRACT
Background: Morbidity, use of healthcare and
medication use have been reported to vary across
groups of migrants and according to the different
phases of migration, but little is known about children
with immigrant background. In this study, we
investigate whether the immigrant children’s age of
arrival predicts differences in usage of primary
healthcare (PHC) and in use of prescribed medication.
Methods: This nationwide, population-based study
used information for children under 18 years of age in
2008 from three linked registers in Norway. Use of
medication was assessed with logistic regression
analyses presented with ORs with 95% CIs.
Results: Of 1 168 365 children, 119 251 had
immigrant background. The mean number of PHC
visits among children aged 10–18 years, was 1.19 for
non-immigrants, 1.17 among second generation
immigrants, 1.12, 1.05 and 0.83 among first
immigrant children who were <5, 5–9 and ≥10 years at
arrival in Norway, respectively. Patterns were similar for
younger immigrants, and were confirmed with
regression models adjusting for age and sex. First
generation immigrant children used less of nearly all
groups of prescribed medication compared to non-
immigrants when adjusting for age and sex (overall OR
0.48 (0.47 to 0.49)), and medication was also
generally less used among second generation
immigrant children (overall OR 0.92 (0.91 to 0.94)).
Conclusions: Age of arrival predicted PHC usage
among children among first-generation children. First-
generation immigrant children, particularly those
arriving later in adolescence, used PHC less than age
corresponding non-immigrant children. Immigrant
children used less prescribed medication compared to
non-immigrants after adjustment for age and sex.
INTRODUCTION
Increasing mobility has led to 214 million
migrants living outside their home coun-
tries.1 The United Nations declaration of
human rights states that all have the right to
adequate medical care, independent of
national origin.2 However, several studies
have shown that healthcare access, usage of
healthcare services and morbidity varies
between non-immigrants and different
groups of immigrants, and changes through
the different phases of migration.3–5 Several
studies show that health-seeking behaviour is
lower among recently arrived adult immi-
grants, but increases some years after immi-
gration.6–8 One hypothesis is that ‘the
healthy immigrant effect’, which has been
reported mostly among adults,9 10 diminishes
with increasing length of stay parallelly with a
transition in culture and behavioural pat-
terns11 Although the decision process for
children is more complex as children’s
access to healthcare is partially decided by
their parents,12 our hypothesis was that the
healthy migrant effect was present also
among children and even more pronounced
among the recently arrived first generation
children.
Language differences and differences in
expressing health problems, as well as insuffi-
cient knowledge of organisation and struc-
ture of the local health systems,13 can also
Strengths and limitations of this study
▪ Healthcare data were collected with quality
control measures in a setting with confidentiality
also minimises recall biases and social
desirability.
▪ The study had a national coverage which avoids
selection biases, and gives numbers that allow
us to classify immigrants in more homogeneous
groups.
▪ Data on unregistered immigrants were not
available.
▪ The study does not include privately provided
healthcare, but this type of healthcare is used to
limited degree in Norway.
▪ It was difficult to assess to which degree the
health needs of immigrants were met.
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constitute barriers hampering the delivery of health ser-
vices for migrants, especially at arrival. However, this can
be counteracted by the use of qualified interpreters
making the services more accessible and useful for
immigrants, and preventing medical errors.14–17 In con-
trast, some studies point to more blood tests being con-
ducted when there is a lack of immigrant background
concordance between the health professional and the
patients.7 Thus, our hypothesis was that blood tests were
used more frequently in assessment of immigrants due
to potential communication barriers leading to uncer-
tainty among clinicians.
Although several studies have assessed how different
groups of immigrants use primary health services,18
fewer have reported on this for children.19 A study from
Norway showed that first generation immigrant children
used primary healthcare (PHC) significantly less than
non-immigrants when adjusting for age and sex, while
second generation immigrant children generally used
PHC more.20
By comparing non-immigrant children to first and
second generation immigrant children living in Norway,
this nationwide, population-based study assesses the
hypothesis on age of arrival and length of stay as predic-
tors of usage of PHC, use of any blood tests and/or use
of interpreter during medical consultations. Further, we
compared differences in purchased medication among
the same groups.
METHODS
This study used register data from the National Population
Register in Norway (NPR), the Norwegian Health
Economics Administration Database (HELFO) and
Anatomical Therapeutic Chemical (ATC) codes from the
Norwegian Prescription Database (NorPD) for the year
2008.21 22 These registers were linked using personal identi-
fication numbers assigned to all non-immigrants and regis-
tered immigrants staying in Norway for at least 6 months.
At the time of the study, Norway had a registered popula-
tion of 4 737 200 of which 1 168 000 were children aged
18 years or less.23 Immigrants were defined as children
with both parents born abroad, and were further classified
into first (born abroad) and second generation (born in
Norway, but both parents being immigrants) and accord-
ing to their parents’ country of origin information regard-
ing sex, age, country of origin for the child and parents,
and age at arrival in Norway was obtained from NPR. We
opted not to include children with mixed background with
one of the parents from Norway or adopted children with
two parents from Norway assuming that these share many
similarities with those categorised as non-immigrants as at
least one of the parents is familiar with Norwegian culture,
traditions and national system structures including the
Norwegian healthcare system and to larger extent speak
Norwegian at home.
The HELFO database contains administrative claims
for PHC for all patient contacts including both contacts
with GPs and emergency room (ER). Also from the
HELFO database we obtained information regarding use
of interpreter and use of any laboratory analyses per-
formed on blood samples. Both the use of interpreter or
of any blood tests during consultations in a PHC in the
year 2008 were dichotomised (into used vs not used) and
assessed only among those who had used a PHC in 2008.
Medication use among children was assessed accord-
ing to the ATC coding system for antimicrobial medica-
tions ( J01A-X, J02, J05), hormonal contraceptives
(G03A), psychoanaleptics (N06A-B), antiepileptics
(N03), non-steroidal anti-inflammatory drugs (NSAIDS,
M01A), corticosteroids for dermatological (D07) and
nasal use (R01AD), antihistamins (R06), drugs for
obstructive airways (R03A, R03BA), immunosuppressants
(L04A), insulin (A10A) and thyroid hormones
(H03AA). For each ATC group a dichotomised variable
indicating if a given ATC group was used in 2008 was
created. The Norwegian Prescription Database includes
all prescriptions dispensed in Norwegians pharmacies.
In Norway, the health system is structured around GPs
providing PHC for a defined group of patients during
standard working time while also staffing ER health ser-
vices for an extended area out-of-hours. GPs are respon-
sible for initial assessments including investigation and
treatment of patients of all ages, and refer to secondary
care when needed. Children in Norway under the age of
16 years are provided with free healthcare, while those
above 16 years of age cover some limited costs.
Analysis
Descriptive statistics including percentages and means
are presented. As the age-of-arrival variable was linked
with age, most analyses were conducted in age-restricted
groups including only children aged 10–18 years or with
age adjustments, in addition to parallel analyses without
restriction made available in online supplementary
tables. Relative use of different types of PHC services
measured by count variables was analysed with negative
binomial regression including unadjusted models and
models adjusted by age and sex. Incidence risk ratios
(IRR) were calculated with 95% CIs. Similarly, to
compare the use of interpreter and the use of blood tests
between first and second generation immigrants and
non-immigrants, negative binomial regression models
adjusted by age and sex were conducted including only
the children who used PCH services in 2008 using a
count variable of the outcome. The use of medication
was measured as dichotomised variables for each of the
ATC groups studied and analysed by logistic regression
models adjusted by age and sex to calculate ORs with
95% CIs. These data are presented in forest plots. Stata
SE11 and SPSS V.20.0 were used for statistical analyses.
RESULTS
Our data comprised 926 044 children born in Norway of
Norwegian parents and 119 251 immigrant children, of
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which 49 014 were first generation and 70 237 were
second generation immigrants (table 1). Among the
immigrants, 82 006 originated from Asia, Africa and
Latin America, 24 609 from Eastern Europe, 7012 from
Western Europe, 4885 from other Nordic countries and
826 from North America and Oceania. In addition,
123 070 children had a mixed background (eg, children
with at least one Norwegian parent), and are not pre-
sented in the analyses below. First generation children
from Asia, Africa and Latin America had moved to
Norway at a slightly higher age compared to the other
immigrants. The sex distribution was balanced and
similar for immigrants and non-immigrants. The mean
age was 11.1 years among first generation immigrant
children, 7.1 years among second generation immigrant
children and 9.3 years among non-immigrants. The cor-
relation coefficient between age at arrival and length of
stay without restricting age was −0.36. In the age
restricted groups with children between 10 and 18 years
of age, the correlation coefficient was −0.83.
Use of health services
The mean number of visits per year to PHC services
including GPs, and ER services for children stratified by
age at the time of the study (2008) is presented in
table 2 and online supplementary table S1. For children
10 years or above in 2008, the mean number of visits in
the same year ranged from 0.83 for those who were
10 years or older at arrival in Norway, 1.17 for second
generation immigrants, to 1.19 for non-immigrants. For
this group, regression models assessing relative use of
PHC indicated slightly less PHC usage among second
generation immigrants compared to non-immigrants,
and lower usage among first generation immigrants and
particularly those arriving as adolescents (table 3).
Results including all children are presented in online
supplementary table S2, showing higher usage for
second-generation immigrants and lower usage for first
generation immigrants. In all models, for first-
generation immigrants there was lower rate of use of
PHC as the age of arrival to Norway increased.
Immigrants from all regions used PHC less than non-
immigrants, with the largest differences seen among
immigrants from North America and Oceania, IRR 0.60
(0.54 to 0.67).
Use of interpreter
Among children who had attended PHC in 2008, an
interpreter was registered for 12.9% of first generation
immigrants and 8.3% of the second generation immi-
grants (and among 0.07% of non-immigrants). An inter-
preter was more often used among immigrants from
Asia, Africa, and Latin America compared to immigrants
from Nordic countries (IRR 6.0 (4.6 to 7.8)), and more
often among immigrants arriving after 10 years of age
compared to second generation immigrants born in
Norway (IRR 7.8 (6.9 to 8.8), see online supplementary
table S3).
Table 1 Background characteristics of the population included.
Non-immigrants
Second
generation Arrival <5 years Arrival 5–9 years Arrival ≥10 years
n Per cent n Per cent n Per cent n Per cent n Per cent
Sex of child
Boys 475 250 51 35 975 51 9099 50 8629 51 7343 52
Girls 450 794 49 34 309 49 8975 50 8217 49 6791 48
Age in years
0–1 91 127 10 12 657 18 1202 7 0 0 0 0
2–4 135 071 15 15 201 22 5102 28 0 0 0 0
5–9 233 934 25 19 678 28 5579 31 6027 36 0 0
10–18 465 912 50 22 748 32 6191 34 10 819 64 14 134 100
Area of origin
Asia, Africa and
Latin America
54 519 78 9041 50 9913 59 8533 60
North America and
Oceania
179 0 261 1 206 1 180 1
Nordic countries 2123 3 1399 8 877 5 486 3
Norway 926 044 100
Western Europe 2232 3 1961 11 1529 9 1290 9
Eastern Europe 11 231 16 5412 30 4321 26 3645 26
World bank income category
Norway-HIC 926 044 100
HIC 9805 14 6945 38 5861 35 5073 36
MIC 49 375 70 7737 43 6908 41 5313 38
LIC 11 057 16 3377 19 4065 24 3735 26
Categories of immigration are grouped depending on age of arrival.
HIC, higher-income country; LIC, lower-income country; MIC, middle-income country.
Fadnes LT, Diaz E. BMJ Open 2017;7:e014641. doi:10.1136/bmjopen-2016-014641 3
Open Access
group.bmj.com on January 10, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
Use of blood tests
Among those who had used PHC, blood tests were regis-
tered in 2008 for 55% of non-immigrants, 55% of first
generation immigrants and 63% of second generation
immigrants. More specifically, a test for C reactive
protein was registered for 38% of non-immigrants, 37%
of first generation immigrants and 51% of second gener-
ation immigrants. Blood testing was slightly more often
used in consultations with immigrants from Eastern
Europe (IRR 1.13 (1.10 to 1.15), see online
supplementary table S4) and Asia, Africa and Latin
America (IRR 1.17 (1.16 to 1.19)) compared to non-
immigrants, but less often among immigrants from
North America and Oceania (IRR 0.75 (0.64 to 0.87))
and Western Europe (IRR 0.82 (0.78 to 0.86)). Blood
testing was also more often used among second
Table 2 Number of visits to different primary healthcare services including GP, ER and combined primary healthcare
including GP and ER for immigrant children grouped depending on age of arrival in Norway (presented with different age
stratifications)
Use of GP Use of ER Primary care use
Mean Mean Mean
Age stratified 10 years or above
Non-immigrants 1.06 0.13 1.19
Second-generation immigrants 1.05 0.12 1.17
First generation: <5 years at arrival 1.01 0.11 1.12
First generation: 5–9 years at arrival 0.95 0.10 1.05
First generation: ≥10 years at arrival 0.75 0.08 0.83
Age stratified <5 years
Non-immigrants 1.76 0.30 2.06
Second-generation immigrants 2.16 0.45 2.60
First generation: <5 years at arrival 1.35 0.24 1.59
Age stratified 5–10 years
Non-immigrants 1.03 0.15 1.19
Second-generation immigrants 1.51 0.26 1.77
First generation: <5 years at arrival 1.32 0.16 1.49
First generation: 5–9 years at arrival 0.75 0.09 0.84
Unstratified
Non-immigrants 1.23 0.18 1.40
Second-generation immigrants 1.62 0.29 1.91
First generation: <5 years at arrival 1.23 0.17 1.40
First generation: 5–9 years at arrival 0.88 0.09 0.98
First generation: ≥10 years at arrival 0.75 0.08 0.83
ER, emergency room; GP, general practitioner.
Table 3 Relative use of GP’s healthcare, ER healthcare and combined primary healthcare including GP and ER reported as
IRR with 95% CIs assessed with negative binomial regression models among children
Use of GP Use of ER Primary care use
IRR (95%CI) IRR (95%CI) IRR (95%CI)
Model 1: Adjusted by age and sex
Non-immigrants (reference) 1 1 1
Second-generation immigrants 0.96 (0.94 to 0.98) 0.87 (0.83 to 0.91) 0.95 (0.93 to 0.97)
<5 years at arrival 0.96 (0.95 to 0.98) 0.89 (0.85 to 0.93) 0.96 (0.94 to 0.97)
5–9 years at arrival 0.76 (0.75 to 0.78) 0.61 (0.57 to 0.64) 0.75 (0.73 to 0.76)
10 years or above at arrival 0.71 (0.70 to 0.73) 0.64 (0.60 to 0.69) 0.71 (0.69 to 0.73)
Model 2: adjusted by age and sex
Non-immigrants (reference) 1 1 1
Nordic countries 0.81 (0.77 to 0.85) 0.77 (0.68 to 0.86) 0.80 (0.76 to 0.84)
Western Europe 0.66 (0.63 to 0.68) 0.45 (0.40 to 0.50) 0.63 (0.61 to 0.66)
Eastern Europe 0.79 (0.78 to 0.81) 0.77 (0.73 to 0.81) 0.79 (0.77 to 0.81)
North America and Oceania 0.62 (0.55 to 0.69) 0.47 (0.35 to 0.62) 0.60 (0.54 to 0.67)
Asia, Africa and Latin America 0.93 (0.92 to 0.94) 0.83 (0.80 to 0.85) 0.92 (0.91 to 0.93)
Models were adjusted by age and sex and restricted to current age of 10 years or above. In model 1, first generation immigrants were
grouped depending on age of arrival and in model 2, first and second generation immigrants were grouped depending on area of origin.
ER, emergency room; GP, general practitioner; IRR, incidence risk rtaio.
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generation immigrants compared to non-immigrants
(IRR 1.24 (1.22 to 1.25), but slightly less used among
generation immigrants (IRR 0.95 (0.93 to 0.96).
Use of medications
When studying children 10 years or older in 2008, first
generation immigrants used less of nearly all assessed
groups of prescribed medications compared to non-
immigrants when adjusting for age and sex, with an
overall OR of 0.48 (0.47 to 0.49) (figure 1). The overall
pattern among second generation immigrant children
aged 10 years or above was less use of medications com-
pared to non-immigrants (OR 0.92 (0.91 to 0.94),
figure 2). Similar patterns, but with higher use of antimi-
crobials in second generation children, were observed
when including all ages in the analyses (see online
supplementary figure S1 and S2). In the adjusted ana-
lysis of each of the ATC groups separately, first gener-
ation children used less off all assessed medications than
non-immigrants, while second generation immigrant
children used more dermatological and nasal corticos-
teroids when including only those 10 years and older
and also slightly more antimicrobial medications and
antihistamins when including all children. In all age
groups, second generation children used less antiepilep-
tics, psychoanaleptics, hormonal contraceptives, insulin
and NSAIDS compared to non-immigrants (see online
supplementary tables S5 and S6).
DISCUSSION
Immigrant children in this study used PHC and medica-
tion significantly less than non-immigrants when adjust-
ing for age and sex. The lowest use was registered for
first generation immigrants and especially children arriv-
ing later in childhood. All immigrants groups used PHC
less often than non-immigrants with the largest differ-
ence between immigrants from North America and
Oceania and non-immigrants. Among those attending to
PHC, an interpreter was used significantly more often
among first generation immigrants from Asia, Africa and
Latin America and blood tests were used slightly more
often for second generation immigrants compared to
non-immigrants, with no differences between first gener-
ation immigrants compared to non-immigrants.
The observed differences in PHC and medication
usage could have various causes. On the one hand, our
results fit with our hypothesis that ‘the healthy immi-
grant effect’ reported among adults9 10 is more import-
ant for immigrant children who arrive in Norway at an
older age correlating. However, it should be noted that
age of arrival for first generation immigrant children
will correlate with length of stay in these data—particu-
larly for analyses using narrow age strata. In these data
we cannot fully distinguish between effects related to
age of arrival and length of stay effects. Length of stay
has been found to be strongly associated with healthcare
use in other settings.8 According to the healthy migrant
Figure 1 Forest plot presenting differences in use of several groups of medications adjusted for age and sex reported as ORs
with 95% CIs assessed with logistic regression models. Comparisons are done between non-immigrants and first-generation
immigrants (restricted to current age of 10 years or above). NSAIDs, non-steroidal anti-inflammatory drugs.
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theory there might be a degree of selection among
immigrants in morbidity. Regarding first generation
immigrant children, it is not unlikely that the sickest
children, especially the youngest ones, do not start or
complete their journeys, while among second generation
children, who are born in Norway, this selection effect, if
at all present, would only apply through the previous
selection of their parents. Furthermore, statistics from
Norway indicate that immigrant infants born in Norway
with mothers from low-income countries have higher
mortality than children with non-immigrants back-
ground,24 which would accord to our results of second
generation children using the system more when includ-
ing also the youngest children in the analyses. Another
possible explanation for our findings could be that the
stress and strain associated with the immigration process
itself have more severe health consequences for small
children than for teen-age children causing more
health-seeking behaviour in this group. In favour of this
hypothesis, a review summarising trauma among refu-
gees indicated slightly higher burden among refugees
arriving during adolescence than as adults.25 On the
other hand, acculturation is generally quicker in
younger age contributing to reducing the stress.26
However, differences in morbidity among the children
might not be the only explaining factor. As parents
often have a strong degree of influence on when chil-
dren should seek healthcare,12 parallel patterns between
children and adults in PHC usage would not be surpris-
ing. Studies have shown that adults increase their use of
PHC with increasing length of stay in the country,27 and
this could also affect second generation children, whose
parents have lived longer in Norway. Also, a Danish
study showing differences in vaccination between differ-
ent immigrant groups indicated that perceptions and
knowledge contribute to differences in use of health
services.28
The variations in use of medication might also be due
to differences in the parents’ perceptions or knowledge
on use of medications, or to financial barriers to access
medicines. As adjusting for number of health visits gave
similar results (results not shown), it is unlikely that vari-
ation in health-seeking behaviour alone explains the dif-
ferences in medication use. It is possible that immigrants
to a stronger degree buy medications abroad. However,
the difference in medication use between first generation
immigrant children and non-immigrants was more pro-
nounced for drugs for chronic disease such as obstructive
airways and psychoanaleptics, which to larger degree are
covered by public funding in Norway and less for systemic
antibacterial medications, which could indicate that
financial barriers are less important in explaining the dif-
ferences in prescribed medications. Other reasons to
explain less use of medication could be that the first gen-
eration immigrant children lived with higher degree of
morbidity without seeking help, or less response to
Figure 2 Forest plot presenting differences in use of different group of medications adjusted for age and sex reported as ORs
with 95% CIs assessed with logistic regression models. Comparisons are done between non-immigrants and second-generation
immigrants (restricted to current age of 10 years or above). NSAIDs, non-steroidal anti-inflammatory drugs.
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medications due to genetic differences between groups
from various ethnicities, such as generally less effect of
commonly used medications for asthma among those of
African ancestry.29 Our results are in accordance with
studies among children in Sweden, the Netherlands and
Spain that have shown lower usage of prescribed medica-
tions among first generation immigrant children com-
pared to non-immigrants.5 30–34
An interpreter had been used for about a tenth of the
immigrant children, mostly among immigrants from
Asia, Africa and Latin America, who were more likely to
have larger differences in language and culture, and
also more among those arriving in Norway during ado-
lescence having had fewer years to adjust culturally and
linguistically compared with those arriving earlier. This
corresponds well with the findings from Canada indicat-
ing that those with language proficiency and who had
stayed in Canada for 10 years or more used healthcare
more than those who had not.8 17 Even though inter-
preters were commonly used among children with back-
ground from low-income countries arriving in
adolescence, the language barrier might still have con-
tributed to reduced usage. The more frequent use of
blood tests among second generation immigrants and
mainly from Asia, Africa and Latin America could fit
with the hypothesis of a larger language and cultural
barrier leading to a higher degree of clinical uncertainty
among healthcare providers. Another possibility could
be that the clinicians are less experienced to meet the
needs of immigrants,35 but could also be linked with dif-
ferences in expectations among the patients.
It is likely that the health-seeking behaviour and the
procedures taking place in the consultations are influ-
enced to different degree by clinicians, the children and
their care takers.12 Even though the clinicians are the
ones making decisions on the use of blood tests and
interpreters in the consultations, choices are also influ-
enced by the children and their caretakers.8
Similarly, caretakers and their children are usually the
main decision makers in health-seeking behaviour, but
this is also influenced by both the clinicians and other
factors.17
Our study have several strengths including its national
coverage limiting selection biases, and numbers that allow
us to classify immigrants in groups according to age of
arrival while ensuring sufficient analytic power even
though heterogeneity inside groups still exists. The use of
healthcare registered data collected with several quality
control measures in a setting with confidentiality also mini-
mises recall biases, social desirabilityand contributes to
good data quality for many of the included variables.
However, our study also has some limitations. As it is based
on national registers, unregistered immigrants are not
included, whose healthcare access is likely to be lower.36 It
is also difficult to assess to which degree the health needs
of immigrants are met. Some variables that could have
been useful, such as sociodemographic variables of the
family, were not possible to link to the children included.
Data on these among adults in Norway show that immi-
grants particularly from low-income countries more often
had a lower income and education than non-
immigrants.37 We would expect the same to be true for the
parents of the included children. Our study does not
include privately provided healthcare, but this type of care
is used to limited degree in Norway.
In conclusion, this study supports the hypothesis that age
of arrival or length of stay predicts PHC usage for children.
Immigrant children used PHC less than age corresponding
non-immigrant children, particularly among first gener-
ation children arriving later in adolescence. First gener-
ation immigrant children used less of nearly all groups of
prescribed medications compared to non-immigrants when
adjusting for age and sex. The differences in PHC usage
between non-immigrants and second generation immigrant
children were mostly linked to differences in age, with
overall slightly less use of prescribed medications among
second generation immigrant children. Regarding the use
of any blood tests in PHC, the picture was more mixed with
slightly more use among immigrants with larger language
differences and less use among other immigrants.
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